← Browse by Condition
Medical Condition
metastatic colorectal adenocarcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 3
ClinicalMetric aggregates all active clinical trials for metastatic colorectal adenocarcinoma from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.
- Recruiting trials — currently enrolling participants, with eligibility criteria
- Phase 1–4 studies — from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary for every trial listing
NCT06336902 Phase 1
Recruiting
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
Enrollment
15 pts
Location
United States
Sponsor
University of Southern Califor...
NCT05673148 Phase 3
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Enrollment
364 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...